Cardinal Health, Inc. $CAH Stock Holdings Lowered by Metis Global Partners LLC

Metis Global Partners LLC cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,115 shares of the company’s stock after selling 919 shares during the period. Metis Global Partners LLC’s holdings in Cardinal Health were worth $2,539,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CAH. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI increased its stake in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares in the last quarter. Nuveen LLC purchased a new position in Cardinal Health in the 1st quarter worth about $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new stake in Cardinal Health during the 1st quarter worth about $104,951,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This represents a 15.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last 90 days. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $203.40 on Monday. The stock has a market cap of $48.33 billion, a price-to-earnings ratio of 31.53, a PEG ratio of 1.39 and a beta of 0.72. The business has a 50 day simple moving average of $160.02 and a 200 day simple moving average of $156.87. Cardinal Health, Inc. has a 52 week low of $114.60 and a 52 week high of $203.67.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.

Wall Street Analyst Weigh In

Several research analysts have commented on CAH shares. Mizuho raised their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Citigroup raised their price objective on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Robert W. Baird set a $232.00 target price on Cardinal Health in a research note on Friday, October 31st. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Wells Fargo & Company raised their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $205.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.